Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses. In Onkológia. ISSN 1336-8176. Bratislava : SOLEN, 2014, 2014, roč. 9, č. 6, s. 404-405.